Impact of Lockdown Measures on Health Outcomes of Adults with Type 2 Diabetes Mellitus in Bangladesh.

Bangladesh COVID-19 Type 2 Diabetes Mellitus lockdown medical records symptom control

Journal

Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525

Informations de publication

Date de publication:
21 Apr 2023
Historique:
received: 17 03 2023
revised: 11 04 2023
accepted: 18 04 2023
medline: 28 4 2023
pubmed: 28 4 2023
entrez: 28 4 2023
Statut: epublish

Résumé

COVID-19 lockdown measures appreciably affected patients' lifestyles, negatively impacting on their health. This includes patients with Type 2 Diabetes Mellitus (T2DM). Care of these patients was also negatively impacted due to a priority to treat patients with COVID-19, certainly initially, within hospitals and clinics in Bangladesh, combined with a lack of access to clinics and physicians due to lockdown and other measures. This is a concern in Bangladesh with growing rates of T2DM and subsequent complications. Consequently, we sought to critically analyze the situation among patients with T2DM in Bangladesh during the initial stages of the pandemic to address this information gap and provide future direction. Overall, 731 patients were recruited by a simple random sampling method among patients attending hospitals in Bangladesh, with data collected over 3 timescales: before lockdown, during the pandemic, and after lockdown. Data extracted from patients' notes included current prescribed medicines and key parameters, including blood sugar levels, blood pressure, and comorbidities. In addition, the extent of record keeping. The glycemic status of patients deteriorated during lockdown, and comorbidities as well as complications related to T2DM increased during this period. Overall, a significant proportion of key datasets were not recorded in patients' notes by their physician before and during lockdown. This started to change after lockdown measures eased. In conclusion, lockdown measures critically affected the management of patients with T2DM in Bangladesh, building on previous concerns. Extending internet coverage for telemedicine, introduction of structured guidelines, and appreciably increasing data recording during consultations is of the utmost priority to improve the care of T2DM patients in Bangladesh.

Identifiants

pubmed: 37108025
pii: healthcare11081191
doi: 10.3390/healthcare11081191
pmc: PMC10137871
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

MMWR Morb Mortal Wkly Rep. 2020 Mar 20;69(11):307-311
pubmed: 32191691
PLoS One. 2022 May 3;17(5):e0267243
pubmed: 35503777
Diabetes Ther. 2020 May;11(5):1091-1101
pubmed: 32221846
Breast Cancer (Dove Med Press). 2023 Jan 27;15:51-89
pubmed: 36733464
BMC Health Serv Res. 2020 Jun 8;20(1):520
pubmed: 32513164
Diabetes Metab Syndr Obes. 2021 Jan 11;14:85-97
pubmed: 33469326
Heliyon. 2020 Oct 30;6(10):e05392
pubmed: 33163666
Diabetes Metab Syndr. 2020 Sep - Oct;14(5):949-952
pubmed: 32604013
Cureus. 2021 Oct 5;13(10):e18489
pubmed: 34754650
JAMA Netw Open. 2020 Oct 1;3(10):e2021476
pubmed: 33006622
Saudi Med J. 2016 Mar;37(3):268-73
pubmed: 26905348
PLoS One. 2021 Apr 6;16(4):e0249222
pubmed: 33822807
BMJ Glob Health. 2017 Jan 3;2(1):e000033
pubmed: 28588991
BMJ Open Diabetes Res Care. 2017 Aug 8;5(1):e000427
pubmed: 28878941
Glob Public Health. 2022 Jul;17(7):1299-1313
pubmed: 33966607
Ophthalmic Epidemiol. 2013 Aug;20(4):220-7
pubmed: 23865602
BMC Nephrol. 2018 Feb 9;19(1):36
pubmed: 29426298
J Diabetes Res. 2018 Feb 26;2018:6093595
pubmed: 29682580
Front Nutr. 2021 Jun 02;8:671004
pubmed: 34150828
PLoS One. 2020 Nov 20;15(11):e0242415
pubmed: 33216783
Hosp Pract (1995). 2018 Oct;46(4):214-220
pubmed: 30058409
PLoS One. 2022 Aug 5;17(8):e0272609
pubmed: 35930581
J Stroke Cerebrovasc Dis. 2017 Dec;26(12):2769-2777
pubmed: 28756905
BMJ Glob Health. 2019 Feb 27;4(1):e001258
pubmed: 30899566
BMC Health Serv Res. 2019 Aug 27;19(1):601
pubmed: 31455307
Cochrane Database Syst Rev. 2020 Apr 8;4:CD013574
pubmed: 32267544
Clin Infect Dis. 2021 May 4;72(9):e334-e342
pubmed: 32738143
Diabetes Care. 2013 Oct;36(10):3227-33
pubmed: 23780946
Arch Public Health. 2021 Aug 21;79(1):150
pubmed: 34419145
JAMA. 2020 Jul 28;324(4):321-323
pubmed: 32556122
Endocr Pract. 2017 Apr;23(Suppl 2):1-87
pubmed: 28437620
Kidney Int. 2016 Dec;90(6):1175-1183
pubmed: 27884312
Comput Biol Med. 2021 Nov;138:104878
pubmed: 34592585
Heliyon. 2020 May;6(5):e04063
pubmed: 32462098
Diabetes Metab Syndr. 2020 Nov-Dec;14(6):1963-1966
pubmed: 33059299
Am J Manag Care. 2021 Dec;27(20 Suppl):S369-S374
pubmed: 34878754
Diabetes Metab Syndr. 2020 May - Jun;14(3):211-212
pubmed: 32172175
J Family Med Prim Care. 2021 Jul;10(7):2529-2532
pubmed: 34568131
J Eval Clin Pract. 2020 Dec;26(6):1592-1598
pubmed: 32970386
J Nutr Health Aging. 2020;24(9):938-947
pubmed: 33155618
Health Sci Rep. 2021 Oct 01;4(4):e386
pubmed: 34622020
Front Biosci (Elite Ed). 2021 Dec 20;13(2):291-298
pubmed: 34937315
BMC Endocr Disord. 2020 Mar 10;20(1):36
pubmed: 32151249
Lancet Diabetes Endocrinol. 2022 Jan;10(1):8-10
pubmed: 34838158
Lancet. 2003 Jun 14;361(9374):2005-16
pubmed: 12814710
BMC Public Health. 2021 Jul 22;21(1):1445
pubmed: 34294059
Clin Hypertens. 2022 Dec 1;28(1):35
pubmed: 36451199
Ghana Med J. 2017 Jun;51(2):56-63
pubmed: 28955101
J Health Serv Res Policy. 2023 Jan;28(1):58-65
pubmed: 35786026
Diabetes Care. 2011 Feb;34(2):363-8
pubmed: 21270194
BMJ. 2021 Nov 17;375:e068302
pubmed: 34789505
Prim Care Diabetes. 2021 Oct;15(5):778-785
pubmed: 34210639
Diabetes Metab Syndr. 2019 Mar - Apr;13(2):1615-1622
pubmed: 31336530
Respiration. 2015;89(3):253-64
pubmed: 25677307
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1562-1569.e1
pubmed: 33181340
F1000Res. 2021 Jun 2;10:435
pubmed: 34925767
Mymensingh Med J. 2019 Jan;28(1):91-95
pubmed: 30755556
World J Diabetes. 2015 Oct 10;6(13):1246-58
pubmed: 26468341
Diabetes Metab Syndr Obes. 2022 Sep 19;15:2857-2865
pubmed: 36160467
BMJ Open. 2022 Oct 6;12(10):e064284
pubmed: 36202580
Healthcare (Basel). 2021 Nov 08;9(11):
pubmed: 34828564
Hosp Pract (1995). 2019 Feb;47(1):34-41
pubmed: 30311819
BMJ Open. 2019 Jul 23;9(7):e026807
pubmed: 31340960
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):579-582
pubmed: 32416527
PLOS Glob Public Health. 2022 Apr 20;2(4):e0000266
pubmed: 36962220
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):319-323
pubmed: 32298984
PLoS One. 2021 Jul 29;16(7):e0255534
pubmed: 34324556
EClinicalMedicine. 2021 Aug;38:101035
pubmed: 34308301
Diabetes Metab Syndr. 2019 Sep - Oct;13(5):2939-2946
pubmed: 31425960
BMC Nurs. 2022 May 24;21(1):124
pubmed: 35610635
Front Public Health. 2021 Jun 24;9:671961
pubmed: 34249838
Hosp Pract (1995). 2021 Oct;49(4):266-272
pubmed: 33734004
Clin Chim Acta. 2020 Sep;508:254-266
pubmed: 32474009
Endocrine. 2022 May;76(2):273-281
pubmed: 35072900
Lancet. 2021 Dec 19;396(10267):2019-2082
pubmed: 33189186
BMC Public Health. 2021 May 29;21(1):1015
pubmed: 34051769
Recent Pat Endocr Metab Immune Drug Discov. 2015;9(2):121-33
pubmed: 26152133
Nutrients. 2020 Aug 04;12(8):
pubmed: 32759636
Front Public Health. 2021 Jul 19;9:711762
pubmed: 34350154
Lancet. 2020 May 30;395(10238):1678-1680
pubmed: 32401713
Healthcare (Basel). 2021 Dec 13;9(12):
pubmed: 34946448

Auteurs

Farhana Akter (F)

Department of Endocrinology, Chittagong Medical College Hospital, Chattogram 4203, Bangladesh.

Ahsanul Haq (A)

Infectious Diseases Division, icddr, b, Mohakhali, Dhaka 1212, Bangladesh.

Brian Godman (B)

Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK.
Division of Public Health Pharmacy and Management, School of Pharmacy, Sefako Makgatho Health Sciences University, Pretoria 0208, South Africa.
Centre of Medical and Bio-Allied Health Sciences Research, Ajman University, Ajman 346, United Arab Emirates.

Kona Chowdhury (K)

Department of Pediatrics, Gonoshasthaya Samaj Vittik Medical College, Dhaka 1344, Bangladesh.

Santosh Kumar (S)

Department of Periodontology and Implantology, Karnavati School of Dentistry, Karnavati University, Gandhinagar 382422, Gujarat, India.

Mainul Haque (M)

Unit of Pharmacology, Faculty of Medicine and Defence Health, Universiti Pertahanan Nasional Malaysia (National Defence University of Malaysia), Kem Perdana Sungai Besi, Kuala Lumpur 57000, Malaysia.

Classifications MeSH